ArticleTurkish journal of pharmaceutical sciences2026
Pharmacist-Led Ambulatory Blood Pressure Monitoring in Community Pharmacy: An Operational Feasibility Case Series.
Article in Turkish journal of pharmaceutical sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: To evaluate the operational feasibility of pharmacist-led ambulatory blood pressure monitoring (ABPM) in community pharmacy practice. Materials and Methods: This operational-feasibility case series recruited eligible participants from four community pharmacies located in three geographical districts in Malta over a three-month recruitment period. Process feasibility included recruitment uptake and participant acceptability. Management feasibility included the completion of a valid 24-hour ABPM recording and successful tracking of post-referral outcomes. Pragmatic post-hoc benchmarks were applied: uptake of at least 60%, completion of valid recordings of at least 80%, and post-referral outcome tracking of at least 80%. Exact 95% confidence intervals (CIs) were calculated using the Clopper-Pearson method. Results: Ten of 20 invited participants consented, corresponding to an uptake rate of 50% (95% CI, 27.2-72.8%). Valid 24-hour ABPM recordings meeting the pre-defined recording quality criteria were obtained for 9 of the 10 participants, corresponding to a completion rate of 90% (95% CI 55.5-99.7). 4 participants were referred for physician review, and post-referral outcomes were obtained for all 4 participants, corresponding to a tracking rate of 100% (95% CI 39.8-100.0). Three of the 4 referred participants reported an intensification of their antihypertensive treatment. Conclusion: Pharmacist-led ABPM in community pharmacies demonstrated operational feasibility regarding completion of valid recordings and post-referral tracking, although uptake requires improvement. Participant-reported treatment changes should be interpreted as exploratory signals, and larger implementation studies are warranted.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.